Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

689
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
689
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

tRF-17-9L5FZU3 is a novel prognostic biomarker and therapeutic target for esophageal squamous cell carcinoma: mechanisms involving RhoB suppression.

Archives of biochemistry and biophysics·2026
Same author

Disruption of Pik3r1 promotes muscle hyperplasia and lipolysis in grass carp (Ctenopharyngodon idella).

Comparative biochemistry and physiology. Part A, Molecular & integrative physiology·2026
Same author

Balancing optimism versus potential risks of AI-driven drug discovery.

Expert opinion on drug discovery·2026
Same author

PyMolGen: Database-Driven Molecular Generation of Drug-Like Compounds.

Journal of chemical information and modeling·2026
Same author

Proposed Biosynthesis of the Complex Ring-Fused Diterpene Rameswaralide. Mechanistic Insights Using Density Functional Theory.

The Journal of organic chemistry·2026
Same author

Sphingosine-1-Phosphate Receptor 3 Confers Tumor Metastasis in Lung Cancer Resistant to Third-Generation EGFR Inhibitor.

MedComm·2026

Related Experiment Video

Updated: Jun 18, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K

Artificial intelligence for small molecule anticancer drug discovery.

Lihui Duo1, Yu Liu1, Jianfeng Ren1

  • 1Faculty of Science and Engineering, University of Nottingham Ningbo China, Ningbo, China.

Expert Opinion on Drug Discovery
|July 29, 2024
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) and machine learning (ML) are revolutionizing small-molecule cancer drug discovery. These technologies accelerate the identification of novel anticancer agents, overcoming limitations of traditional methods.

Keywords:
Drug discoveryartificial intelligencecancermachine learningsmall molecules

More Related Videos

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.6K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.7K

Related Experiment Videos

Last Updated: Jun 18, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.6K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.7K

Area of Science:

  • Oncology
  • Pharmacology
  • Bioinformatics

Background:

  • Targeted cancer therapy with small molecules has improved outcomes but faces challenges like drug resistance and low response rates.
  • Conventional drug discovery is time-consuming and expensive, necessitating more efficient methods.
  • Artificial intelligence (AI) and large datasets are transforming small-molecule anticancer drug discovery.

Purpose of the Study:

  • To review historical landmarks of AI-driven drug discovery.
  • To highlight AI applications in small-molecule cancer drug discovery.
  • To outline challenges and future research directions in AI-driven oncology.

Main Methods:

  • Review of AI applications in drug discovery.
  • Analysis of machine learning (ML) and deep learning (DL) techniques.
  • Examination of genomic, proteomic, and imaging data analysis.

Main Results:

  • AI enables rapid identification and development of novel anticancer agents.
  • AI analyzes vast datasets to uncover hidden patterns in cancer research.
  • Advancements promise breakthroughs in personalized and precision oncology.

Conclusions:

  • AI is revolutionizing oncology research and drug discovery.
  • Despite challenges, AI offers significant potential for future cancer management.
  • AI-driven approaches are crucial for overcoming limitations in targeted cancer therapy.